| ■ 영문 제목 : Global IBS-C Drug Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K00053 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 81 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 IBS-C 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (아미티자, 락투로스, 마그네시아 우유, LINZESS (리나크로티드), 기타)와 용도별 시장규모 (병원 약국, 소매 약국, 온라인 약국) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 IBS-C 치료제 시장 점유율 - 지역별 IBS-C 치료제 시장규모 - 주요지역의 종류별 시장규모 (아미티자, 락투로스, 마그네시아 우유, LINZESS (리나크로티드), 기타) - 주요지역의 용도별 시장규모 (병원 약국, 소매 약국, 온라인 약국) - 미주의 IBS-C 치료제 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 IBS-C 치료제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 IBS-C 치료제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 IBS-C 치료제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 IBS-C 치료제 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Allergan, Takeda, Sucampo Pharmaceuticals, IM HealthScience - 조사의 결과/결론 |
According to this latest study, the 2021 growth of IBS-C Drug will have significant change from previous year. By the most conservative estimates of global IBS-C Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the IBS-C Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of IBS-C Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Amitiza
Lactulose
Milk of Magnesia
LINZESS (Linaclotide)
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Allergan
Takeda
Sucampo Pharmaceuticals
IM HealthScience
1 Scope of the Report 2 Executive Summary 3 Global IBS-C Drug by Company 4 IBS-C Drug by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global IBS-C Drug Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. IBS-C Drug Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Amitiza Table 3. Major Players of Lactulose Table 4. Major Players of Milk of Magnesia Table 5. Major Players of LINZESS (Linaclotide) Table 6. Major Players of Others Table 7. Global IBS-C Drug Sales by Type (2016-2021) & (K Units) Table 8. Global IBS-C Drug Sales Market Share by Type (2016-2021) Table 9. Global IBS-C Drug Revenue by Type (2016-2021) & ($ million) Table 10. Global IBS-C Drug Revenue Market Share by Type (2016-2021) Table 11. Global IBS-C Drug Sale Price by Type (2016-2021) Table 12. Global IBS-C Drug Sales by Distribution Channel (2016-2021) & (K Units) Table 13. Global IBS-C Drug Sales Market Share by Distribution Channel (2016-2021) Table 14. Global IBS-C Drug Value by Distribution Channel (2016-2021) Table 15. Global IBS-C Drug Revenue Market Share by Distribution Channel (2016-2021) Table 16. Global IBS-C Drug Sale Price by Distribution Channel (2016-2021) Table 17. Global IBS-C Drug Sales by Company (2019-2021) & (K Units) Table 18. Global IBS-C Drug Sales Market Share by Company (2019-2021) Table 19. Global IBS-C Drug Revenue by Company (2019-2021) ($ Millions) Table 20. Global IBS-C Drug Revenue Market Share by Company (2019-2021) Table 21. Global IBS-C Drug Sale Price by Company (2019-2021) Table 22. Key Manufacturers IBS-C Drug Producing Area Distribution and Sales Area Table 23. Players IBS-C Drug Products Offered Table 24. IBS-C Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 25. New Products and Potential Entrants Table 26. Mergers & Acquisitions, Expansion Table 27. Global IBS-C Drug Sales by Region (2016-2021) (K Units) Table 28. Global IBS-C Drug Sales Market Share by Region (2016-2021) Table 29. Global IBS-C Drug Revenue by Region (2016-2021) & ($ Millions) Table 30. Global IBS-C Drug Revenue Market Share by Region (2016-2021) Table 31. Americas IBS-C Drug Sales by Country (2016-2021) & (K Units) Table 32. Americas IBS-C Drug Sales Market Share by Country (2016-2021) Table 33. Americas IBS-C Drug Revenue by Country (2016-2021) & ($ Millions) Table 34. Americas IBS-C Drug Revenue Market Share by Country (2016-2021) Table 35. Americas IBS-C Drug Sales by Type (2016-2021) & (K Units) Table 36. Americas IBS-C Drug Sales Market Share by Type (2016-2021) Table 37. Americas IBS-C Drug Sales by Distribution Channel (2016-2021) & (K Units) Table 38. Americas IBS-C Drug Sales Market Share by Distribution Channel (2016-2021) Table 39. APAC IBS-C Drug Sales by Region (2016-2021) & (K Units) Table 40. APAC IBS-C Drug Sales Market Share by Region (2016-2021) Table 41. APAC IBS-C Drug Revenue by Region (2016-2021) & ($ Millions) Table 42. APAC IBS-C Drug Revenue Market Share by Region (2016-2021) Table 43. APAC IBS-C Drug Sales by Type (2016-2021) & (K Units) Table 44. APAC IBS-C Drug Sales Market Share by Type (2016-2021) Table 45. APAC IBS-C Drug Sales by Distribution Channel (2016-2021) & (K Units) Table 46. APAC IBS-C Drug Sales Market Share by Distribution Channel (2016-2021) Table 47. Europe IBS-C Drug Sales by Country (2016-2021) & (K Units) Table 48. Europe IBS-C Drug Sales Market Share by Country (2016-2021) Table 49. Europe IBS-C Drug Revenue by Country (2016-2021) & ($ Millions) Table 50. Europe IBS-C Drug Revenue Market Share by Country (2016-2021) Table 51. Europe IBS-C Drug Sales by Type (2016-2021) & (K Units) Table 52. Europe IBS-C Drug Sales Market Share by Type (2016-2021) Table 53. Europe IBS-C Drug Sales by Distribution Channel (2016-2021) & (K Units) Table 54. Europe IBS-C Drug Sales Market Share by Distribution Channel (2016-2021) Table 55. Middle East & Africa IBS-C Drug Sales by Country (2016-2021) & (K Units) Table 56. Middle East & Africa IBS-C Drug Sales Market Share by Country (2016-2021) Table 57. Middle East & Africa IBS-C Drug Revenue by Country (2016-2021) & ($ Millions) Table 58. Middle East & Africa IBS-C Drug Revenue Market Share by Country (2016-2021) Table 59. Middle East & Africa IBS-C Drug Sales by Type (2016-2021) & (K Units) Table 60. Middle East & Africa IBS-C Drug Sales Market Share by Type (2016-2021) Table 61. Middle East & Africa IBS-C Drug Sales by Distribution Channel (2016-2021) & (K Units) Table 62. Middle East & Africa IBS-C Drug Sales Market Share by Distribution Channel (2016-2021) Table 63. Key and Potential Regions of IBS-C Drug Table 64. Key Application and Potential Industries of IBS-C Drug Table 65. Key Challenges of IBS-C Drug Table 66. Key Trends of IBS-C Drug Table 67. IBS-C Drug Distributors List Table 68. IBS-C Drug Customer List Table 69. Global IBS-C Drug Sales Forecast by Region (2021-2026) & (K Units) Table 70. Global IBS-C Drug Consumption Market Forecast by Region Table 71. Global IBS-C Drug Revenue Forecast by Region (2021-2026) & ($ millions) Table 72. Global IBS-C Drug Revenue Market Share Forecast by Region (2021-2026) Table 73. Americas IBS-C Drug Sales Forecast by Country (2021-2026) & (K Units) Table 74. Americas IBS-C Drug Revenue Forecast by Country (2021-2026) & ($ millions) Table 75. APAC IBS-C Drug Sales Forecast by Region (2021-2026) & (K Units) Table 76. APAC IBS-C Drug Revenue Forecast by Region (2021-2026) & ($ millions) Table 77. Europe IBS-C Drug Sales Forecast by Country (2021-2026) & (K Units) Table 78. Europe IBS-C Drug Revenue Forecast by Country (2021-2026) & ($ millions) Table 79. Middle East & Africa IBS-C Drug Sales Forecast by Country (2021-2026) & (K Units) Table 80. Middle East & Africa IBS-C Drug Revenue Forecast by Country (2021-2026) & ($ millions) Table 81. Global IBS-C Drug Sales Forecast by Type (2021-2026) & (K Units) Table 82. Global IBS-C Drug Sales Market Share Forecast by Type (2021-2026) Table 83. Global IBS-C Drug Revenue Forecast by Type (2021-2026) & ($ Millions) Table 84. Global IBS-C Drug Revenue Market Share Forecast by Type (2021-2026) Table 85. Global IBS-C Drug Sales Forecast by Distribution Channel (2021-2026) & (K Units) Table 86. Global IBS-C Drug Sales Market Share Forecast by Distribution Channel (2021-2026) Table 87. Global IBS-C Drug Revenue Forecast by Distribution Channel (2021-2026) & ($ Millions) Table 88. Global IBS-C Drug Revenue Market Share Forecast by Distribution Channel (2021-2026) Table 89. Allergan Basic Information, IBS-C Drug Manufacturing Base, Sales Area and Its Competitors Table 90. Allergan IBS-C Drug Product Offered Table 91. Allergan IBS-C Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 92. Allergan Main Business Table 93. Allergan Latest Developments Table 94. Takeda Basic Information, IBS-C Drug Manufacturing Base, Sales Area and Its Competitors Table 95. Takeda IBS-C Drug Product Offered Table 96. Takeda IBS-C Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 97. Takeda Main Business Table 98. Takeda Latest Developments Table 99. Sucampo Pharmaceuticals Basic Information, IBS-C Drug Manufacturing Base, Sales Area and Its Competitors Table 100. Sucampo Pharmaceuticals IBS-C Drug Product Offered Table 101. Sucampo Pharmaceuticals IBS-C Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 102. Sucampo Pharmaceuticals Main Business Table 103. Sucampo Pharmaceuticals Latest Developments Table 104. IM HealthScience Basic Information, IBS-C Drug Manufacturing Base, Sales Area and Its Competitors Table 105. IM HealthScience IBS-C Drug Product Offered Table 106. IM HealthScience IBS-C Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 107. IM HealthScience Main Business Table 108. IM HealthScience Latest Developments List of Figures Figure 1. Picture of IBS-C Drug Figure 2. IBS-C Drug Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global IBS-C Drug Sales Growth Rate 2016-2026 (K Units) Figure 7. Global IBS-C Drug Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. IBS-C Drug Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Amitiza Figure 10. Product Picture of Lactulose Figure 11. Product Picture of Milk of Magnesia Figure 12. Product Picture of LINZESS (Linaclotide) Figure 13. Product Picture of Others Figure 14. Global IBS-C Drug Sales Market Share by Type in 2020 Figure 15. Global IBS-C Drug Revenue Market Share by Type (2016-2021) Figure 16. IBS-C Drug Consumed in Hospital Pharmacies Figure 17. Global IBS-C Drug Market: Hospital Pharmacies (2016-2021) & (K Units) Figure 18. IBS-C Drug Consumed in Retail Pharmacies Figure 19. Global IBS-C Drug Market: Retail Pharmacies (2016-2021) & (K Units) Figure 20. IBS-C Drug Consumed in Online Pharmacies Figure 21. Global IBS-C Drug Market: Online Pharmacies (2016-2021) & (K Units) Figure 22. Global IBS-C Drug Sales Market Share by Distribution Channel (2016-2021) Figure 23. Global IBS-C Drug Revenue Market Share by Distribution Channel in 2020 Figure 24. IBS-C Drug Revenue Market by Company in 2020 ($ Million) Figure 25. Global IBS-C Drug Revenue Market Share by Company in 2020 Figure 26. Global IBS-C Drug Sales Market Share by Regions (2016-2021) Figure 27. Global IBS-C Drug Revenue Market Share by Region in 2020 Figure 28. Americas IBS-C Drug Sales 2016-2021 (K Units) Figure 29. Americas IBS-C Drug Revenue 2016-2021 ($ Millions) Figure 30. APAC IBS-C Drug Sales 2016-2021 (K Units) Figure 31. APAC IBS-C Drug Revenue 2016-2021 ($ Millions) Figure 32. Europe IBS-C Drug Sales 2016-2021 (K Units) Figure 33. Europe IBS-C Drug Revenue 2016-2021 ($ Millions) Figure 34. Middle East & Africa IBS-C Drug Sales 2016-2021 (K Units) Figure 35. Middle East & Africa IBS-C Drug Revenue 2016-2021 ($ Millions) Figure 36. Americas IBS-C Drug Sales Market Share by Country in 2020 Figure 37. Americas IBS-C Drug Revenue Market Share by Country in 2020 Figure 38. Americas IBS-C Drug Sales Market Share by Type in 2020 Figure 39. Americas IBS-C Drug Sales Market Share by Distribution Channel in 2020 Figure 40. United States IBS-C Drug Revenue Growth 2016-2021 ($ Millions) Figure 41. Canada IBS-C Drug Revenue Growth 2016-2021 ($ Millions) Figure 42. Mexico IBS-C Drug Revenue Growth 2016-2021 ($ Millions) Figure 43. Brazil IBS-C Drug Revenue Growth 2016-2021 ($ Millions) Figure 44. APAC IBS-C Drug Sales Market Share by Region in 2020 Figure 45. APAC IBS-C Drug Revenue Market Share by Regions in 2020 Figure 46. APAC IBS-C Drug Sales Market Share by Type in 2020 Figure 47. APAC IBS-C Drug Sales Market Share by Distribution Channel in 2020 Figure 48. China IBS-C Drug Revenue Growth 2016-2021 ($ Millions) Figure 49. Japan IBS-C Drug Revenue Growth 2016-2021 ($ Millions) Figure 50. Korea IBS-C Drug Revenue Growth 2016-2021 ($ Millions) Figure 51. Southeast Asia IBS-C Drug Revenue Growth 2016-2021 ($ Millions) Figure 52. India IBS-C Drug Revenue Growth 2016-2021 ($ Millions) Figure 53. Australia IBS-C Drug Revenue Growth 2016-2021 ($ Millions) Figure 54. Europe IBS-C Drug Sales Market Share by Country in 2020 Figure 55. Europe IBS-C Drug Revenue Market Share by Country in 2020 Figure 56. Europe IBS-C Drug Sales Market Share by Type in 2020 Figure 57. Europe IBS-C Drug Sales Market Share by Distribution Channel in 2020 Figure 58. Germany IBS-C Drug Revenue Growth 2016-2021 ($ Millions) Figure 59. France IBS-C Drug Revenue Growth 2016-2021 ($ Millions) Figure 60. UK IBS-C Drug Revenue Growth 2016-2021 ($ Millions) Figure 61. Italy IBS-C Drug Revenue Growth 2016-2021 ($ Millions) Figure 62. Russia IBS-C Drug Revenue Growth 2016-2021 ($ Millions) Figure 63. Middle East & Africa IBS-C Drug Sales Market Share by Country in 2020 Figure 64. Middle East & Africa IBS-C Drug Revenue Market Share by Country in 2020 Figure 65. Middle East & Africa IBS-C Drug Sales Market Share by Type in 2020 Figure 66. Middle East & Africa IBS-C Drug Sales Market Share by Distribution Channel in 2020 Figure 67. Egypt IBS-C Drug Revenue Growth 2016-2021 ($ Millions) Figure 68. South Africa IBS-C Drug Revenue Growth 2016-2021 ($ Millions) Figure 69. Israel IBS-C Drug Revenue Growth 2016-2021 ($ Millions) Figure 70. Turkey IBS-C Drug Revenue Growth 2016-2021 ($ Millions) Figure 71. GCC Country IBS-C Drug Revenue Growth 2016-2021 ($ Millions) Figure 72. Channels of Distribution Figure 73. Distributors Profiles |
| ※본 조사보고서 [세계의 IBS-C 치료제 시장예측 2021년-2026년] (코드 : LPI-2201K00053) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 IBS-C 치료제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |